Tatsuru Ota

Itabashi, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A patient presenting with isolated hematuria and renal dysfunction as rare manifestation of cryoglobulinemic glomerulonephritis in the course of autoimmune diseases including Sjögren's syndrome.

A patient presenting with isolated hematuria and renal dysfunction as rare manifestation of cryoglobulinemic glomerulonephritis in the course of autoimmune diseases including Sjögren's syndrome.

Journal: CEN case reports

Published: March 01, 2018

Remission of Refractory Ascites and Discontinuation of Hemodialysis after Additional Rituximab to Long-term Glucocorticoid Therapy in a Patient with TAFRO Syndrome.

Remission of Refractory Ascites and Discontinuation of Hemodialysis after Additional Rituximab to Long-term Glucocorticoid Therapy in a Patient with TAFRO Syndrome.

Journal: Internal medicine (Tokyo, Japan)

Published: January 12, 2018

Emergence of Smoldering ANCA-associated Glomerulonephritis during the Clinical Course of Mixed Connective Tissue Disease and Sjögren's Syndrome.

Emergence of Smoldering ANCA-associated Glomerulonephritis during the Clinical Course of Mixed Connective Tissue Disease and Sjögren's Syndrome.

Journal: Internal medicine (Tokyo, Japan)

Published: December 23, 2017

Discontinuation of Hemodialysis in a Patient with Anti-GBM Disease by the Treatment with Corticosteroids and Plasmapheresis despite Several Predictors for Dialysis-Dependence.

Discontinuation of Hemodialysis in a Patient with Anti-GBM Disease by the Treatment with Corticosteroids and Plasmapheresis despite Several Predictors for Dialysis-Dependence.

Journal: Case reports in nephrology

Published: July 21, 2017

Unique proximal tubular cell injury and the development of acute kidney injury in adult patients with minimal change nephrotic syndrome.

Unique proximal tubular cell injury and the development of acute kidney injury in adult patients with minimal change nephrotic syndrome.

Journal: BMC nephrology

Published: July 13, 2017

Clinical Presentation of Tubulointerstitial Nephritis Caused by Amyloid Light-chain Amyloidosis in a Patient with Sjögren's Syndrome.

Clinical Presentation of Tubulointerstitial Nephritis Caused by Amyloid Light-chain Amyloidosis in a Patient with Sjögren's Syndrome.

Journal: Internal medicine (Tokyo, Japan)

Published: February 17, 2017

Time to target uric acid to retard CKD progression.

Time to target uric acid to retard CKD progression.

Journal: Clinical and experimental nephrology

Published: March 29, 2016

Pathological implications of linear immunoglobulin G staining on the glomerular capillary walls in a case of infection-related glomerulonephritis.

Pathological implications of linear immunoglobulin G staining on the glomerular capillary walls in a case of infection-related glomerulonephritis.

Journal: Pathology international

Published: March 02, 2016

The Impact of Normal Range of Serum Phosphorus on the Incidence of End-Stage Renal Disease by A Propensity Score Analysis.

The Impact of Normal Range of Serum Phosphorus on the Incidence of End-Stage Renal Disease by A Propensity Score Analysis.

Journal: PloS one

Published: January 28, 2016

Kidney diseases and metabolic disorders--Basics and applications required for general physicians. Topics: I. Disorders of water balance and sodium metabolism

Kidney diseases and metabolic disorders--Basics and applications required for general physicians. Topics: I. Disorders of water balance and sodium metabolism

Journal: Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine

Published: November 24, 2015

Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease--A Propensity Score Analysis.

Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease--A Propensity Score Analysis.

Journal: PloS one

Published: October 12, 2015

Long-term efficacy of vildagliptin in patients with type 2 diabetes undergoing hemodialysis.

Long-term efficacy of vildagliptin in patients with type 2 diabetes undergoing hemodialysis.

Journal: Journal of diabetes and metabolic disorders

Published: July 30, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026